HEPATITIS C VIRUS INHIBITORS

This disclosure concerns novel compounds of Formula (I) or as defined in the specification and compositions comprising such novel compounds. These compounds are useful antiviral agents, especially in inhibiting the function of the NS5A protein encoded by Hepatitis C virus (HCV). Thus, the disclosure...

Full description

Saved in:
Bibliographic Details
Main Authors HAMANN, Lawrence G, BENDER, John A, BELEMA, Makonen, LAVOIE, Rico, RUEDIGER, Edward H, BACHAND, Carol, ROMINE, Jeffrey Lee, CHEN, Qi, LOPEZ, Omar D, KADOW, John F
Format Patent
LanguageEnglish
French
German
Published 15.02.2017
Subjects
CHEMISTRY
HETEROCYCLIC COMPOUNDS
METALLURGY
ORGANIC CHEMISTRY
Online AccessGet full text

Cover

Abstract This disclosure concerns novel compounds of Formula (I) or as defined in the specification and compositions comprising such novel compounds. These compounds are useful antiviral agents, especially in inhibiting the function of the NS5A protein encoded by Hepatitis C virus (HCV). Thus, the disclosure also concerns a method of treating HCV related diseases or conditions by use of these novel compounds or a composition comprising such novel compounds.
AbstractList This disclosure concerns novel compounds of Formula (I) or as defined in the specification and compositions comprising such novel compounds. These compounds are useful antiviral agents, especially in inhibiting the function of the NS5A protein encoded by Hepatitis C virus (HCV). Thus, the disclosure also concerns a method of treating HCV related diseases or conditions by use of these novel compounds or a composition comprising such novel compounds.
Author BENDER, John A
HAMANN, Lawrence G
BACHAND, Carol
CHEN, Qi
RUEDIGER, Edward H
LAVOIE, Rico
LOPEZ, Omar D
KADOW, John F
BELEMA, Makonen
ROMINE, Jeffrey Lee
Author_xml – fullname: HAMANN, Lawrence G
– fullname: BENDER, John A
– fullname: BELEMA, Makonen
– fullname: LAVOIE, Rico
– fullname: RUEDIGER, Edward H
– fullname: BACHAND, Carol
– fullname: ROMINE, Jeffrey Lee
– fullname: CHEN, Qi
– fullname: LOPEZ, Omar D
– fullname: KADOW, John F
BookMark eNrjYmDJy89L5WSQ8XANcAzxDPEMVnBWCPMMCg1W8PTz8HTyDPEPCuZhYE1LzClO5YXS3AwKbq4hzh66qQX58anFBYnJqXmpJfGuAUYmlpaGxkZOhsZEKAEADsYiSQ
ContentType Patent
DBID EVB
DatabaseName esp@cenet
DatabaseTitleList
Database_xml – sequence: 1
  dbid: EVB
  name: esp@cenet
  url: http://worldwide.espacenet.com/singleLineSearch?locale=en_EP
  sourceTypes: Open Access Repository
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
Chemistry
Sciences
DocumentTitleAlternate INHIBITEURS DU VIRUS DE L'HÉPATITE C
HEMMER DES HEPATITIS-C-VIRUS
ExternalDocumentID EP2499132B1
GroupedDBID EVB
ID FETCH-epo_espacenet_EP2499132B13
IEDL.DBID EVB
IngestDate Fri Jul 19 13:02:04 EDT 2024
IsOpenAccess true
IsPeerReviewed false
IsScholarly false
Language English
French
German
LinkModel DirectLink
MergedId FETCHMERGED-epo_espacenet_EP2499132B13
Notes Application Number: EP20100779401
OpenAccessLink https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20170215&DB=EPODOC&CC=EP&NR=2499132B1
ParticipantIDs epo_espacenet_EP2499132B1
PublicationCentury 2000
PublicationDate 20170215
PublicationDateYYYYMMDD 2017-02-15
PublicationDate_xml – month: 02
  year: 2017
  text: 20170215
  day: 15
PublicationDecade 2010
PublicationYear 2017
RelatedCompanies Bristol-Myers Squibb Company
RelatedCompanies_xml – name: Bristol-Myers Squibb Company
Score 3.0709152
Snippet This disclosure concerns novel compounds of Formula (I) or as defined in the specification and compositions comprising such novel compounds. These compounds...
SourceID epo
SourceType Open Access Repository
SubjectTerms CHEMISTRY
HETEROCYCLIC COMPOUNDS
METALLURGY
ORGANIC CHEMISTRY
Title HEPATITIS C VIRUS INHIBITORS
URI https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20170215&DB=EPODOC&locale=&CC=EP&NR=2499132B1
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwY2BQSUsB3WOcaqRrnGJgrgvsf5npJgL7trpJBpbJFkmpaQYpRqDNyb5-Zh6hJl4RphFMDJmwvTDgc0LLwYcjAnNUMjC_l4DL6wLEIJYLeG1lsX5SJlAo394txNZFDdo7NjQHVWFqLk62rgH-Lv7Oas7OQJaaX5AtsJdhCex4OQE7SqzAVrQ5uM8W5gTalFKAXKO4CTKwBQANyysRYmBKzRNm4HSGXbwmzMDhC53vBjKhWa9YhEHGwzXAMcQzxDNYwVkhzDMoNFjB08_D08kzxD8oWJRBwc01xNlDF2hNPNxL8a4BcAcZizGwAHv6qRIMCsmWqcbJaZYWScBOi0mKsXESaHdRKugKTXPDZGNzc0kGSZzGSOGRk2bgAoUNaLGxoakMA0tJUWmqLLAuLUmSA4cCAFXidHY
link.rule.ids 230,309,783,888,25577,76883
linkProvider European Patent Office
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfZ1LT4NAEIAnTTXWm1aN1aocDDcilLbAgRh5hdXyCNCmN-LCkvTSNhbj33eW0OpFb5vdZPaRzM5-uzM7AI9VyfMYs5GklrImIX9NpXdkW4nKRqFTVsnliAcnB-HUn49fl5NlB1b7WJjmn9Cv5nNE1KgC9b1u9uvtzyWW0_hW7p7oCqs2z15mOmJLx4rGTZjoWKYbR05ki7aNJTFMTKQMA8HLQlA6whO23pDSwuJBKdvfFsU7g-MYha3rc-iwdR969j7xWh9Ogva9G4ut6u0uYOi78UtGMpIKtrAgyTwVSOgTi2RRkl6C4LmZ7UvYTX6YUu7GhwGpV9BF0mfXIBQGU4vK0ClCy7hUVcqjixhPoakphappAxj8Kebmn7YH6PlZMMtnJHy7hVO-TtzxWJkMoVt_fLI7tKs1vW9W5BvzF3dm
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Apatent&rft.title=HEPATITIS+C+VIRUS+INHIBITORS&rft.inventor=HAMANN%2C+Lawrence+G&rft.inventor=BENDER%2C+John+A&rft.inventor=BELEMA%2C+Makonen&rft.inventor=LAVOIE%2C+Rico&rft.inventor=RUEDIGER%2C+Edward+H&rft.inventor=BACHAND%2C+Carol&rft.inventor=ROMINE%2C+Jeffrey+Lee&rft.inventor=CHEN%2C+Qi&rft.inventor=LOPEZ%2C+Omar+D&rft.inventor=KADOW%2C+John+F&rft.date=2017-02-15&rft.externalDBID=B1&rft.externalDocID=EP2499132B1